Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Aug
14
2023
FDA Issues New Draft Guidance for Cosmetic Facility Registration and Product Listing Greenberg Traurig, LLP
Aug
14
2023
Defamation Lawsuit Filed Against Researcher Over Comments About Splenda Keller and Heckman LLP
Aug
14
2023
FDA Issues Draft Guidance on Facility Registration under MoCRA Bergeson & Campbell, P.C.
Aug
11
2023
A&W Settles “Aged Vanilla” Class Action Keller and Heckman LLP
Aug
10
2023
Remedies as Big as Your Bamba McDermott Will & Emery
Aug
10
2023
The Tax Implications of Purchasing Craft Producers in the First Half of a Year McDermott Will & Emery
Aug
10
2023
Increase in Foodborne Illnesses Expected due to Climate Change Keller and Heckman LLP
Aug
10
2023
EPA Announces New Webinar Series on the Use of NAMs to Reduce Animal Testing Bergeson & Campbell, P.C.
Aug
10
2023
TRI PFAS Obligations May Expand Considerably CMBG3 Law
Aug
10
2023
FDA Draft Guidance Provides Further Details on New Cosmetic Product Facility Registration and Product Listing Requirements ArentFox Schiff LLP
Aug
10
2023
Modernization of Cosmetics Regulation Act of 2022 ArentFox Schiff LLP
Aug
10
2023
TSCA Section 21 Citizen Petition Seeks Prohibition of 6PPD in Tires Bergeson & Campbell, P.C.
Aug
10
2023
Cosmetic Product Registration and Listing Under MoCRA Comes Closer Beveridge & Diamond PC
Aug
9
2023
FDA Issues Final Administrative Actions on Partially Hydrogenated Oils in Foods Keller and Heckman LLP
Aug
9
2023
FDA Publishes Draft Guidance on Cosmetic Product Facility Registration and Cosmetic Product Listing Mintz
Aug
9
2023
PFAS MDL Settlements Face Additional Questions CMBG3 Law
Aug
8
2023
EUON Publishes Study Identifying Status of Animal-Free Test Methods for Use on Nanomaterials Bergeson & Campbell, P.C.
Aug
8
2023
Third Party Administrator & Pharmacy Benefit Manager 2023 Newsletter Polsinelli PC
Aug
8
2023
FDA Issues Draft Guidance on Registration of Cosmetic Product Facilities and Products Keller and Heckman LLP
Aug
8
2023
The FTC Finalizes Changes to Endorsement Guides Epstein Becker & Green, P.C.
Aug
8
2023
Alabama Medical Cannabis Update: August 10 Appears to Be the Day Bradley Arant Boult Cummings LLP
Aug
8
2023
DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions Foley & Lardner LLP
Aug
7
2023
A Watched Pot Never Boils: SAFE Banking on the Backburner Again Bradley Arant Boult Cummings LLP
Aug
7
2023
California Judge Certifies Class in Bigelow Tea False Advertising Lawsuit Keller and Heckman LLP
Aug
4
2023
FDA Announces Public Meeting to Modernize Recalls Keller and Heckman LLP
Aug
4
2023
Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy McDermott Will & Emery
Aug
3
2023
OECD Publishes Consensus Document on Environmental Considerations for the Release of Transgenic Plants Bergeson & Campbell, P.C.
Aug
3
2023
Good News, Bad News: Congress Wants to Help the Hemp Industry Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins